Sanofi India informs about appointment of CFO

05 Oct 2020 Evaluate
As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the Board of Directors of the Company at its meeting held on 5th October 2020 approved appointment of Vaibhav Karandikar as Chief Financial Officer (CFO) and Key Managerial Personnel with effect from 6th October 2020. A brief profile of Vaibhav Karandikar is enclosed.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

4334.40 -37.30 (-0.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×